These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 33838295)

  • 61. Prevalence of Antibody against Angiotensin II Type 1 Receptor (AT1R) Among Thai Kidney Transplant Patients.
    Viboon S; Townamchai N; Phiancharoen S; Kupatawintu P; Dhitivat V; Nathalang O
    Transplant Proc; 2018 Jun; 50(5):1310-1315. PubMed ID: 29880351
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Incidences of preformed and de novo donor-specific HLA antibodies and their clinicohistological correlates in the early course of kidney transplantation.
    Huang Y; Ramon D; Luan FL; Sung R; Samaniego M
    Clin Transpl; 2012; ():247-56. PubMed ID: 23721029
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Impact on mid-term kidney graft outcomes of pretransplant anti-HLA antibodies detected by solid-phase assays: Do donor-specific antibodies tell the whole story?
    Malheiro J; Tafulo S; Dias L; Martins S; Fonseca I; Beirão I; Castro-Henriques A; Cabrita A
    Hum Immunol; 2017 Sep; 78(9):526-533. PubMed ID: 28732720
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pre-transplant HLA Antibodies and Delayed Graft Function in the Current Era of Kidney Transplantation.
    Morath C; Döhler B; Kälble F; Pego da Silva L; Echterdiek F; Schwenger V; Živčić-Ćosić S; Katalinić N; Kuypers D; Benöhr P; Haubitz M; Ziemann M; Nitschke M; Emmerich F; Pisarski P; Karakizlis H; Weimer R; Ruhenstroth A; Scherer S; Tran TH; Mehrabi A; Zeier M; Süsal C
    Front Immunol; 2020; 11():1886. PubMed ID: 32983110
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The impact of Angiotensin II Type 1 Receptor antibodies on morbidity and mortality in Heart Mate II supported recipients.
    Marian U; Slavcev A; Gazdic T; Ivak P; Netuka I
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Dec; 160(4):518-523. PubMed ID: 27132810
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Anti-angiotensin type 1 receptor antibodies associated with antibody mediated rejection in donor HLA antibody negative patients.
    Reinsmoen NL; Lai CH; Heidecke H; Haas M; Cao K; Ong G; Naim M; Wang Q; Mirocha J; Kahwaji J; Vo AA; Jordan SC; Dragun D
    Transplantation; 2010 Dec; 90(12):1473-7. PubMed ID: 21030904
    [TBL] [Abstract][Full Text] [Related]  

  • 67. C4d-negative antibody-mediated rejection with high anti-angiotensin II type I receptor antibodies in absence of donor-specific antibodies.
    Fuss A; Hope CM; Deayton S; Bennett GD; Holdsworth R; Carroll RP; Coates PT
    Nephrology (Carlton); 2015 Jul; 20(7):467-73. PubMed ID: 25726938
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The Influence of Antibodies against Angiotensin II Type-1 Receptor on the Outcome of Kidney Transplantation: A Single-Center Retrospective Study.
    Filiopoulos V; Vittoraki A; Vallianou K; Bellos I; Markaki P; Liapis G; Marinaki S; Iniotaki A; Boletis IN
    J Clin Med; 2023 Apr; 12(9):. PubMed ID: 37176553
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Non-HLA Antibodies Impact on C4d Staining, Stellate Cell Activation and Fibrosis in Liver Allografts.
    OʼLeary JG; Demetris AJ; Philippe A; Freeman R; Cai J; Heidecke H; Smith C; Hart B; Jennings LW; Catar R; Everly M; Klintmalm GB; Dragun D
    Transplantation; 2017 Oct; 101(10):2399-2409. PubMed ID: 28665894
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Non-HLA Autoantibodies at 1 Year Negatively Affect 5-Year Native Renal Function in Liver Transplant Recipients.
    O'Leary JG; Philippe A; Freeman R; Heidecke H; Jennings LW; Catar R; Klintmalm GB; Dragun D
    Transplant Proc; 2021 Apr; 53(3):1019-1024. PubMed ID: 33579550
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Antibodies Against ARHGDIB and ARHGDIB Gene Expression Associate With Kidney Allograft Outcome.
    Senev A; Otten HG; Kamburova EG; Callemeyn J; Lerut E; Van Sandt V; Kuypers D; Emonds MP; Naesens M
    Transplantation; 2020 Jul; 104(7):1462-1471. PubMed ID: 31651716
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Angiotensin II Type-1 Receptor Antibodies Are Associated With Active Allograft Dysfunction Following Pediatric Liver Transplantation.
    Wozniak LJ; Hickey MJ; Chan AP; Venick RS; Farmer DG; Busuttil RW; Reed EF; McDiarmid SV
    Transplantation; 2020 Dec; 104(12):2547-2556. PubMed ID: 32101982
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Histopathological Relevance of Angiotensin II Type 1 Receptor in Renal Transplant Biopsy.
    Sas A; Donizy P; Kościelska-Kasprzak K; Kamińska D; Mazanowska O; Krajewska M; Chudoba P; Korta K; Hałoń A; Klinger M; Banasik M
    Transplant Proc; 2018; 50(6):1847-1849. PubMed ID: 30056913
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Determining donor-specific antibody C1q-binding ability improves the prediction of antibody-mediated rejection in human leucocyte antigen-incompatible kidney transplantation.
    Malheiro J; Tafulo S; Dias L; Martins S; Fonseca I; Beirão I; Castro-Henriques A; Cabrita A
    Transpl Int; 2017 Apr; 30(4):347-359. PubMed ID: 27717025
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Kidney Transplantation and "Sex Mismatch": A 10-Year Single-Center Analysis.
    Graňák K; Kováčiková L; Skálová P; Vnučák M; Miklušica J; Laca Ľ; Mokáň M; Dedinská I
    Ann Transplant; 2020 Jul; 25():e921117. PubMed ID: 32675801
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Characteristics of Circulating Donor Human Leukocyte Antigen-specific Immunoglobulin G Antibodies Predictive of Acute Antibody-mediated Rejection and Kidney Allograft Failure.
    Kannabhiran D; Lee J; Schwartz JE; Friedlander R; Aull M; Muthukumar T; Campbell S; Epstein D; Seshan SV; Kapur S; Sharma VK; Suthanthiran M; Dadhania D
    Transplantation; 2015 Jun; 99(6):1156-64. PubMed ID: 25629531
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Analysis of preformed donor-specific anti-HLA antibodies characteristics for prediction of antibody-mediated rejection in kidney transplantation.
    Malheiro J; Tafulo S; Dias L; Martins LS; Fonseca I; Beirão I; Castro-Henriques A; Cabrita A
    Transpl Immunol; 2015 Mar; 32(2):66-71. PubMed ID: 25661873
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Association of anti-human leukocyte antigen and anti-angiotensin II type 1 receptor antibodies with liver allograft fibrosis after immunosuppression withdrawal.
    Ohe H; Uchida Y; Yoshizawa A; Hirao H; Taniguchi M; Maruya E; Yurugi K; Hishida R; Maekawa T; Uemoto S; Terasaki PI
    Transplantation; 2014 Nov; 98(10):1105-11. PubMed ID: 24914568
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Graft immunologic events in deceased donor kidney transplant recipients with preformed HLA-donor specific antibodies.
    Ixtlapale-Carmona X; Arvizu A; De-Santiago A; González-Tableros N; López M; Castelán N; Marino LA; Uribe-Uribe NO; Contreras AG; Vilatobá M; Morales-Buenrostro LE; Alberú J
    Transpl Immunol; 2018 Feb; 46():8-13. PubMed ID: 28974434
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Deleterious Impact of Donor-Specific Anti-HLA Antibodies Toward HLA-Cw and HLA-DP in Kidney Transplantation.
    Bachelet T; Martinez C; Del Bello A; Couzi L; Kejji S; Guidicelli G; Lepreux S; Visentin J; Congy-Jolivet N; Rostaing L; Taupin JL; Kamar N; Merville P
    Transplantation; 2016 Jan; 100(1):159-66. PubMed ID: 26262501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.